Jeffrey N. Martin

41.4k total citations · 8 hit papers
340 papers, 23.5k citations indexed

About

Jeffrey N. Martin is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Jeffrey N. Martin has authored 340 papers receiving a total of 23.5k indexed citations (citations by other indexed papers that have themselves been cited), including 187 papers in Infectious Diseases, 164 papers in Virology and 86 papers in Epidemiology. Recurrent topics in Jeffrey N. Martin's work include HIV Research and Treatment (164 papers), HIV/AIDS Research and Interventions (139 papers) and HIV-related health complications and treatments (74 papers). Jeffrey N. Martin is often cited by papers focused on HIV Research and Treatment (164 papers), HIV/AIDS Research and Interventions (139 papers) and HIV-related health complications and treatments (74 papers). Jeffrey N. Martin collaborates with scholars based in United States, Uganda and Canada. Jeffrey N. Martin's co-authors include Steven G. Deeks, Peter W. Hunt, David R. Bangsberg, Elizabeth Sinclair, Frederick Hecht, Priscilla Y. Hsue, Joseph M. McCune, Benigno Rodríguez, Rebecca Hoh and Michael M. Lederman and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Jeffrey N. Martin

334 papers receiving 23.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

2006 2.7k citations Jason M. Brenchley, Timothy W. Schacker et al. profile →
T Cell Activation Is Associated with Lower CD4⁺T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

2003 676 citations Peter W. Hunt, Jeffrey N. Martin et al. The Journal of Infectious Diseases profile →
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load

2004 605 citations Steven G. Deeks, Peter W. Hunt et al. Blood profile →
Sexual Transmission and the Natural History of Human Herpesvirus 8 Infection

1998 514 citations Jeffrey N. Martin, Dennis Osmond et al. profile →
Relationship between T Cell Activation and CD4 ⁺ T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy

2007 506 citations Peter W. Hunt, Jason M. Brenchley et al. The Journal of Infectious Diseases profile →
Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral‐Treated HIV Infection

2009 463 citations Wei Jiang, Michael M. Lederman et al. The Journal of Infectious Diseases profile →
Kaposi sarcoma

2019 402 citations Ethel Cesarman, Jeffrey N. Martin et al. profile →
Tutorial on directed acyclic graphs

2021 186 citations Jeffrey N. Martin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey N. Martin United States	79	11.7k	11.6k	6.7k	5.7k	5.3k	340	23.5k
Michael S. Saag United States	84	19.4k 1.7×	15.5k 1.3×	9.5k 1.4×	3.7k 0.7×	4.7k 0.9×	328	28.8k
Alan Landay United States	82	9.1k 0.8×	12.7k 1.1×	6.6k 1.0×	10.0k 1.8×	5.1k 1.0×	525	27.3k
Peter W. Hunt United States	64	7.9k 0.7×	9.3k 0.8×	4.4k 0.7×	4.6k 0.8×	5.5k 1.0×	281	17.2k
Joseph J. Eron United States	83	20.8k 1.8×	17.1k 1.5×	7.0k 1.0×	2.4k 0.4×	3.8k 0.7×	465	27.9k
Margaret A. Fischl United States	62	16.5k 1.4×	12.5k 1.1×	6.8k 1.0×	2.0k 0.4×	3.4k 0.6×	268	23.5k
John Phair United States	69	11.0k 0.9×	9.5k 0.8×	7.6k 1.1×	4.0k 0.7×	3.0k 0.6×	353	22.0k
Diane V. Havlir United States	68	15.6k 1.3×	11.7k 1.0×	6.8k 1.0×	3.0k 0.5×	3.0k 0.6×	390	22.3k
Stephen J. Gange United States	59	8.1k 0.7×	6.9k 0.6×	4.3k 0.6×	2.4k 0.4×	3.4k 0.6×	237	17.3k
Joseph B. Margolick United States	64	10.2k 0.9×	12.9k 1.1×	4.1k 0.6×	4.8k 0.8×	3.7k 0.7×	257	19.7k
Sharon R. Lewin Australia	67	8.0k 0.7×	9.9k 0.9×	6.6k 1.0×	5.8k 1.0×	2.6k 0.5×	370	19.0k

Countries citing papers authored by Jeffrey N. Martin

Since Specialization

Citations

This map shows the geographic impact of Jeffrey N. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey N. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey N. Martin more than expected).

Fields of papers citing papers by Jeffrey N. Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey N. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey N. Martin. The network helps show where Jeffrey N. Martin may publish in the future.

Co-authorship network of co-authors of Jeffrey N. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey N. Martin. A scholar is included among the top collaborators of Jeffrey N. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey N. Martin. Jeffrey N. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maurer, Toby, et al.. (2025). Peer Navigation for HIV-Associated Kaposi Sarcoma in Kenya: The Power of the Survivor's Voice. JCO Global Oncology. 11(11). e2400494–e2400494.

Musinguzi, Nicholas, Yap Boum, Conrad Muzoora, et al.. (2025). Subtypes A1 and D, and recombinant HIV-1 natural polymorphisms associated with lenacapavir drug resistance in Uganda. Journal of Antimicrobial Chemotherapy. 80(4). 955–961. 1 indexed citations

Fallah, Mosoka, Collin Van Ryn, Moses J Soka, et al.. (2025). Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case–control study. The Lancet Microbe. 6(5). 101033–101033. 1 indexed citations

Takahashi, Saki, Michael J. Peluso, Jill Hakim, et al.. (2023). SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency. American Journal of Epidemiology. 192(9). 1562–1575. 5 indexed citations

Freeman, Esther E., Aggrey Semeere, Devon E. McMahon, et al.. (2021). Beyond T Staging in the “Treat-All” Era: Severity and Heterogeneity of Kaposi Sarcoma in East Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(5). 1119–1127. 11 indexed citations

Butler, Lisa, Robert Inglis, Megan Wenger, et al.. (2020). Using Media to Promote Public Awareness of Early Detection of Kaposi’s Sarcoma in Africa. Journal of Oncology. 2020. 1–13. 1 indexed citations

Ayers, Leona W., Arturo Barbachano-Guerrero, Shane C. McAllister, et al.. (2018). Mast Cell Activation and KSHV Infection in Kaposi Sarcoma. Clinical Cancer Research. 24(20). 5085–5097. 14 indexed citations

Feinstein, Matthew J., June‐Ho Kim, Jeffrey N. Martin, et al.. (2016). Ideal Cardiovascular Health and Carotid Atherosclerosis in a Mixed Cohort of HIV-Infected and Uninfected Ugandans. AIDS Research and Human Retroviruses. 33(1). 49–56. 34 indexed citations

Tandon, Ravi, Glen M. Chew, Persephone Borrow, et al.. (2014). Galectin-9 Is Rapidly Released During Acute HIV-1 Infection and Remains Sustained at High Levels Despite Viral Suppression Even in Elite Controllers. AIDS Research and Human Retroviruses. 30(7). 654–664. 64 indexed citations

10.

Hunt, Peter W., Nancy S. Shulman, Timothy L. Hayes, et al.. (2013). The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial. Blood. 121(23). 4635–4646. 107 indexed citations

11.

Leeansyah, Edwin, Máire F. Quigley, Anders Sönnerborg, et al.. (2012). Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood. 121(7). 1124–1135. 283 indexed citations

12.

Eriksson, Emily M., Jeffrey M. Milush, Emily Ho, et al.. (2011). Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity. Blood. 119(3). 745–755. 30 indexed citations

13.

Hersperger, Adam R., Jeffrey N. Martin, Lucy Y. Shin, et al.. (2011). Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression. Blood. 117(14). 3799–3808. 136 indexed citations

14.

Favre, David, Jeff E. Mold, Peter W. Hunt, et al.. (2010). Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of T _H 17 to Regulatory T Cells in HIV Disease. Science Translational Medicine. 2(32). 32ra36–32ra36. 423 indexed citations

15.

Ferre, April L., Peter W. Hunt, Megan M. Morris, et al.. (2010). Immunodominant HIV-Specific CD8 ⁺ T-Cell Responses Are Common to Blood and Gastrointestinal Mucosa, and Gag-Specific Responses Dominate in Rectal Mucosa of HIV Controllers. Journal of Virology. 84(19). 10354–10365. 49 indexed citations

16.

Jiang, Wei, Michael M. Lederman, Peter W. Hunt, et al.. (2009). Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral‐Treated HIV Infection. The Journal of Infectious Diseases. 199(8). 1177–1185. 463 indexed citations breakdown →

17.

Emu, Brinda, Elizabeth Sinclair, Hiroyu Hatano, et al.. (2008). HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control. Journal of Virology. 82(11). 5398–5407. 174 indexed citations

18.

Hsue, Priscilla Y., Husam H. Farah, Ann F. Bolger, et al.. (2007). Abstract 2287: Diastolic Dysfunction is Common in Asymptomatic HIV Patients. Circulation. 2 indexed citations

19.

Luetkemeyer, Annie, Edwin D. Charlebois, Laura Flores, et al.. (2007). Comparison of an Interferon-γ Release Assay with Tuberculin Skin Testing in HIV-infected Individuals. American Journal of Respiratory and Critical Care Medicine. 175(7). 737–742. 168 indexed citations

20.

Stall, Ron, Lisa M. Pollack, Thomas C. Mills, et al.. (2001). Use of antiretroviral therapies among HIV-infected men who have sex with men: a household-based sample of 4 major American cities. American Journal of Public Health. 91(5). 767–773. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact